The whole point here is that it is subjective - there is not a line pre-drawn in the sand that defines this. This is the WHOLE point why FDA needs to review it and it's not a box-ticking exercise. it's like that ad that went togs togs togs togs undies undies. We all have a different definition of where that line is. and as a group we would 'review the evidence' and determine where the line is.
BUT THEN! Each submission is the very first time ever that the drug has been looked at and needs to go through the review process and determine the requirements.
The whole point here is that it is subjective - there is not a...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $1.784M | 4.691M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248028 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 356327 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |